More Clinuvel Pharmaceuticals Limited news
Clinuvel Pharmaceuticals LimitedASX: CUV

Clinuvel accredits first European EPP expert centres

Mar 14, 2016 at 11:57 PM EDT · Issued by Clinuvel Pharmaceuticals Limited

Filed with ASX · Mar 14, 2016 at 11:57 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/clinuvel-accredits-first-european-epp-expert-centres

Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27↗

Clinuvel Pharmaceuticals Limited on 6ix

Earlier from Clinuvel Pharmaceuticals

  • Clinuvel PlacementMar 14, 2016
  • Clinuvel brief on European commercialisationFeb 15, 2016
  • US FDA orphan designation received for cutaneous porphyriasFeb 11, 2016
  • Update on North American vitiligo program for SCENESSEFeb 10, 2016
  • TGA grants Orphan Drug Designation for SCENESSEFeb 10, 2016

Later from Clinuvel Pharmaceuticals

  • Clinuvel enters a joint venture with Biotech Lab SingaporeMar 30, 2016
  • EMA Oral Explanation UpdateMar 30, 2016
  • JAMA Dermatology publishes SCENESSE vitiligo study resultsMar 30, 2016
  • Clinuvel declines unsolicited proposal from RetrophinMar 30, 2016
  • EMA review of SCENESSE extended to mid-2014Mar 30, 2016
All Clinuvel Pharmaceuticals news releases↗

Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.

Follow Clinuvel Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer